# Selenious Yeast in CLL Patients w/o Indication of Chemotherapy

> **NCT05136378** · NA · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Chronic Lymphocytic Leukemia Stage A(0)
- Chronic Lymphocytic Leukemia Stage A(I)
- Chronic Lymphocytic Leukemia Stage A(II)
- Chronic Lymphocytic Leukaemia Stage B(I)

## Interventions

- **DRUG:** Low Dose Selenious Yeast Tablets
- **DRUG:** High Dose Selenious Yeast Tablets

## Key facts

- **NCT ID:** NCT05136378
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05136378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05136378, "Selenious Yeast in CLL Patients w/o Indication of Chemotherapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05136378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
